Bioventus Z Score

BVS
 Stock
  

USD 7.00  0.07  0.99%   

Altman Z Score is one of the simplest fundamental models to determine how likely your company is to fail. The module uses available fundamental data of a given equity to approximate the Altman Z score. Altman Z Score is determined by evaluating five fundamental price points available from the company's current public disclosure documents. Continue to Bioventus Inc Piotroski F Score and Bioventus Inc Valuation analysis.
  

Bioventus Z Score Analysis

Bioventus Inc's Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..
Z Score 
 = 
Sum Of  
 
5 Factors 
More About Z Score | All Equity Analysis

Current Bioventus Inc Z Score

    
  0.6  
Most of Bioventus Inc's fundamental indicators, such as Z Score, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Bioventus Inc Cl is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
First Factor
 = 
1.2 * (
Working Capital
/
Total Assets )
Second Factor
 = 
1.4 * (
Retained Earnings
/
Total Assets )
Thrid Factor
 = 
3.3 * (
EBITAD
/
Total Assets )
Fouth Factor
 = 
0.6 * (
Market Value of Equity
/
Total Liabilities )
Fifth Factor
 = 
0.99 * (
Revenue
/
Total Assets )
To calculate Z-Score one would need to know current working capital of the company, its total assets, and liabilities, amount of latest retained earnings as well as earnings before interest and tax. Z-Score can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area' with scores of less than 1, indicating the high probability of distress. Z Score is used widely by financial auditors, accountants, money managers, loan processers, wealth advisers, as well as day traders. In the last 25 years, many financial models that utilize z score has been proved to be successful as a predictor of corporate bankruptcy.
Compare to competition

In accordance with the company's disclosures, Bioventus Inc Cl has a Z Score of 0.6. This is 91.11% lower than that of the Healthcare sector and 86.18% lower than that of the Medical Devices industry. The z score for all United States stocks is 93.12% higher than that of the company.

Bioventus Inc Institutional Holders

Institutional Holdings refers to the ownership stake in Bioventus Inc that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Bioventus Inc's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Bioventus Inc's value.
Security TypeSharesValue
Essex Woodlands Management IncCommon Shares12.1 M82.5 M
Juniper Investment Company LlcCommon Shares2.8 M18.8 M
Blackrock IncCommon SharesM13.6 M
Royce Associates LpCommon SharesM13.4 M
Sv Health Investors LlcCommon Shares1.5 M10.2 M
First Light Asset Management LlcCommon Shares1.3 M9.2 M
Redmile Group LlcCommon Shares1.3 M8.9 M

Bioventus Fundamentals

About Bioventus Inc Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Bioventus Inc Cl's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bioventus Inc using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bioventus Inc Cl based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the bodys natural healing process in the United States and internationally. The company was founded in 2011 and is headquartered in Durham, North Carolina. Bioventus Inc operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 1150 people.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Bioventus Inc without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run My Watchlist Analysis Now

   

My Watchlist Analysis

Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
All  Next Launch Module

Pair Trading with Bioventus Inc

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bioventus Inc position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bioventus Inc will appreciate offsetting losses from the drop in the long position's value.

Moving together with Bioventus Inc

+0.71JPMJP Morgan Chase Fiscal Year End 13th of January 2023 PairCorr
The ability to find closely correlated positions to Bioventus Inc could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bioventus Inc when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bioventus Inc - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bioventus Inc Cl to buy it.
The correlation of Bioventus Inc is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bioventus Inc moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bioventus Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bioventus Inc can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Continue to Bioventus Inc Piotroski F Score and Bioventus Inc Valuation analysis. You can also try Analyst Recommendations module to analyst recommendations and target price estimates broken down by several categories.

Complementary Tools for analysis

When running Bioventus Inc price analysis, check to measure Bioventus Inc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bioventus Inc is operating at the current time. Most of Bioventus Inc's value examination focuses on studying past and present price action to predict the probability of Bioventus Inc's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Bioventus Inc's price. Additionally, you may evaluate how the addition of Bioventus Inc to your portfolios can decrease your overall portfolio volatility.
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Go
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Go
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go
Money Managers
Screen money managers from public funds and ETFs managed around the world
Go
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Go
Is Bioventus Inc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bioventus Inc. If investors know Bioventus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bioventus Inc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Bioventus Inc is measured differently than its book value, which is the value of Bioventus that is recorded on the company's balance sheet. Investors also form their own opinion of Bioventus Inc's value that differs from its market value or its book value, called intrinsic value, which is Bioventus Inc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bioventus Inc's market value can be influenced by many factors that don't directly affect Bioventus Inc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bioventus Inc's value and its price as these two are different measures arrived at by different means. Investors typically determine Bioventus Inc value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bioventus Inc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.